Results 251 to 260 of about 284,484 (398)

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Extragonadal germ cell tumors (EGCTs) are rare, with limited prospective data to guide treatment or inform prognosis. Incidence and treatment patterns of EGCT in Australia reflect international data and practices. Compared to testicular primaries, the prognosis of EGCT is poor, especially for primary mediastinal non‐seminoma.
Kar Ven Cavan Chow   +19 more
wiley   +1 more source

The Human Yolk Sac and Yolk Sac Tumors [PDF]

open access: yesJournal of Clinical Pathology, 1994
openaire   +1 more source

Zebrafish as a Model for Toxicological Perturbation of Yolk and Nutrition in the Early Embryo

open access: yesCurrent Environmental Health Reports, 2018
Karilyn E. Sant, A. Timme-Laragy
semanticscholar   +1 more source

B‐Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization

open access: yesAllergy, EarlyView.
IgH repertoire sequencing of a large atopic dermatitis cohort reveal reduced IgE somatic hypermutation and increased IgE diversity associated with food allergen sensitization. Presence of a dog during the first year of life is associated with increased IgE somatic hypermutation, possibly countering the effect of food sensitization.
Kirandeep K. Gill   +18 more
wiley   +1 more source

Genetic Parameters of Egg Quality Traits and Albumen Density in White Leghorn Chickens. [PDF]

open access: yesAnimals (Basel)
Chen A   +9 more
europepmc   +1 more source

BRD9 inhibition as potential treatment option for testicular germ cell tumors

open access: yesAndrology, EarlyView.
Abstract Background Testicular germ cell tumors (TGCT) are the predominant tumor in younger males. Usually, 5‐year survival rates are quite high, but 15–20% of patients with metastatic non‐seminomas are resistant to standard cisplatin‐based therapy.
Aylin Hansen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy